Adverse drug events (ADEs)—injuries caused by medications— are estimated to rank among the leading causes of death in the United States and represent a major, often preventable threat to patient ...

FDA launches new AI-powered system to track drug and vaccine side effects in real time, replacing outdated databases and saving $120 million annually.

WASHINGTON - The Food and Drug Administration has launched what it is describing as a "unified dashboard" for identifying and ...

Adverse drug events are more common in older people with comorbidities, a new study finds. Factors that are independently linked with adverse drug events are being female, taking more drugs daily, ...

The number of medications prescribed to a patient and patient age could be possible risk factors for adverse drug events, according to research published in Health Services Research. For their study, ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to stop independent labs from producing cheaper versions. Former Novo Nordisk CEO ...

March 11 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has introduced a unified platform designed to ...

Despite ongoing debate, medications such as Ozempic continue to rank among the most commonly prescribed treatments for weight ...

Yesterday, the Food and Drug Administration (FDA) announced the launch of the Adverse Event Monitoring System ( AEMS ), a new platform for assessing adverse event reports made to the FDA for drugs, ...

In another development, 25 states have petitioned to join a lawsuit and defend the EPA’s decision to rescind the climate endangerment finding ...

Researchers used a prototype reporting system designed by investigators from the Regenstrief Institute and Indiana University School of Medicine to study causes of medication errors and adverse drug ...

In this study, 3 main themes were identified through patient interviews: perceived relationship with their clinicians, perceived severity of adverse medication events, and patient activation in ...